BLASTS 20 PERCENT OR LESS OF PERIPHERAL BLOOD WHITE CELLS

Clinical trials for BLASTS 20 PERCENT OR LESS OF PERIPHERAL BLOOD WHITE CELLS explained in plain language.

Never miss a new study

Get alerted when new BLASTS 20 PERCENT OR LESS OF PERIPHERAL BLOOD WHITE CELLS trials appear

Sign up with your email to follow new studies for BLASTS 20 PERCENT OR LESS OF PERIPHERAL BLOOD WHITE CELLS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for patients with rare, Hard-to-Treat blood disorders

Disease control Recruiting now

This study is testing whether the drug ruxolitinib can help control rare blood disorders where the body makes too many eosinophils, a type of white blood cell. It will involve about 10 adults whose conditions have not responded well to standard treatments like steroids. The main …

Matched conditions: BLASTS 20 PERCENT OR LESS OF PERIPHERAL BLOOD WHITE CELLS

Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

BLASTS 20 PERCENT OR LESS OF PERIPHERAL BLOOD WHITE CELLS

Get alerted when new BLASTS 20 PERCENT OR LESS OF PERIPHERAL BLOOD WHITE CELLS trials appear

New hope for patients with rare, Hard-to-Treat blood disorders